Pembrolizumab,Vibostolimab,Gebasaxturev,MK-4830,Favezelimab
Merck
['vibostolimab', 'melanoma', 'pembro']
will anti-tigit (finally) be an effective checkpoint? keymaker-uo2 multi-armed trial in neoadjuvant setting, showed addition of the anti-tigit vibostolimab to pembrolizumab yielded a slightly higher orr than pembro alone, but small numbers of patients. #aacr23 #melanoma 
Incoming @ The Angeles Clinic and Research Institute Cedars Sinai affiliate with phase 1 interesr. Frmr phase 1 fellow at MD Anderson & faculty UCI. KU Alum.